Novel Device Contributes to Positive Phlebotomy Experience
By LabMedica International staff writers Posted on 30 May 2018 |

Image: The BD Vacutainer UltraTouch push button blood collection set (Photo courtesy of Becton Dickinson).
Phlebotomy is a necessary procedure that may be a source of pain, stress and anxiety for some patients. While smaller gauge needles are known to lessen patient discomfort, they are often associated with increases in hemolysis or longer tube fill times.
A push button blood collection set has been engineered to minimize patient discomfort during blood collection. This device was evaluated for blood collection and allows clinicians to use a smaller gauge for easier access to small, difficult veins, without compromising tube fill time and sample quality.
Scientists from BD Life Sciences (Franklin Lakes, NJ, USA) conducted two studies with 214 subjects to compare pain and anxiety regarding future phlebotomy with three devices. Another study with 52 subjects assessed hemolysis in specimens collected with the two devices; bench testing evaluated tube-filling times with these devices.
The investigators evaluated the effect of a 5-bevel, 25-gauge blood collection set (BCS) with ultra-thin wall cannula (BD Vacutainer UltraTouch Push Button BCS (UltraTouch) on patient pain and anxiety compared with two 3-bevel, thin-wall, 23-gauge BCSs (BD Vacutainer Safety-Lok (Safety-Lok) and Greiner Bio-One Vacuette (Greiner, Kremsmünster, Austria). Hemolysis was evaluated visually, by Hemolysis Index and hemolysis-sensitive indicators potassium (K) and lactate dehydrogenase (LDH).
In a direct comparison with the BD Vacutainer UltraTouch blood collection set and traditional 23-gauge blood collection wingsets, the 25-gauge UltraTouch push button blood collection set demonstrated a statistically significant, 40% decrease in patient perceptions of insertion pain and 47% decrease in overall pain during blood collection, respectively. In addition, the study showed that the 25-gauge UltraTouch blood collection set did not increase hemolysis or increase tube filling times, in comparison to a traditional 23-gauge blood collection set. There was no significant difference in anxiety regarding future phlebotomy. No increase was observed in Hemolysis Index, K or LDH. Tube-filling times were comparable for each device.
The authors concluded that the 25-gauge UltraTouch provided less overall pain compared with the 23-gauge Vacuette, less pain upon needle insertion than the 23-gauge Safety-Lok, and no compromise in specimen quality or flow rate. The study was originally published in the July 2017 issue of The Journal of Applied Laboratory Medicine and was recently updated by Becton Dickinson.
A push button blood collection set has been engineered to minimize patient discomfort during blood collection. This device was evaluated for blood collection and allows clinicians to use a smaller gauge for easier access to small, difficult veins, without compromising tube fill time and sample quality.
Scientists from BD Life Sciences (Franklin Lakes, NJ, USA) conducted two studies with 214 subjects to compare pain and anxiety regarding future phlebotomy with three devices. Another study with 52 subjects assessed hemolysis in specimens collected with the two devices; bench testing evaluated tube-filling times with these devices.
The investigators evaluated the effect of a 5-bevel, 25-gauge blood collection set (BCS) with ultra-thin wall cannula (BD Vacutainer UltraTouch Push Button BCS (UltraTouch) on patient pain and anxiety compared with two 3-bevel, thin-wall, 23-gauge BCSs (BD Vacutainer Safety-Lok (Safety-Lok) and Greiner Bio-One Vacuette (Greiner, Kremsmünster, Austria). Hemolysis was evaluated visually, by Hemolysis Index and hemolysis-sensitive indicators potassium (K) and lactate dehydrogenase (LDH).
In a direct comparison with the BD Vacutainer UltraTouch blood collection set and traditional 23-gauge blood collection wingsets, the 25-gauge UltraTouch push button blood collection set demonstrated a statistically significant, 40% decrease in patient perceptions of insertion pain and 47% decrease in overall pain during blood collection, respectively. In addition, the study showed that the 25-gauge UltraTouch blood collection set did not increase hemolysis or increase tube filling times, in comparison to a traditional 23-gauge blood collection set. There was no significant difference in anxiety regarding future phlebotomy. No increase was observed in Hemolysis Index, K or LDH. Tube-filling times were comparable for each device.
The authors concluded that the 25-gauge UltraTouch provided less overall pain compared with the 23-gauge Vacuette, less pain upon needle insertion than the 23-gauge Safety-Lok, and no compromise in specimen quality or flow rate. The study was originally published in the July 2017 issue of The Journal of Applied Laboratory Medicine and was recently updated by Becton Dickinson.
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreMolecular Diagnostics
view channel
POC Oral Swab Test to Increase Chances of Pregnancy in IVF
Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more
Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections
Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Blood Test Detects Up to Five Infectious Diseases at POC
Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app.... Read more
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Qiagen Acquires NGS Analysis Software Company Genoox
QIAGEN (Venlo, the Netherlands) has signed a definitive agreement to acquire Genoox (Tel Aviv, Israel), a provider of artificial intelligence (AI)-powered software that enables clinical labs to scale and... Read more
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more